Glypar PM 1mg/500mg/15mg Tablet
Marketer
Ind Swift Laboratories Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glypar PM 1mg/500mg/15mg Tablet
Combiprep DM, a triple-combination tablet (1mg/500mg/15mg), effectively manages blood glucose in adults with type 2 diabetes. Used alongside diet and exercise, it enhances insulin efficiency, reducing blood sugar. Dosage and duration should strictly follow your physician's instructions; always take it with food to prevent gastric discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dose. Excessive intake can cause hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals raises hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Patients with kidney, liver, or heart conditions, pregnant or breastfeeding women must consult their doctor before use. Pre-treatment kidney function tests are standard. Limit alcohol consumption to minimize adverse effects.
Primary Ingredients of Glypar PM 1mg/500mg/15mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Glypar PM 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glypar PM 1mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the Glypar PM 1mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Glypar PM 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glypar PM 1mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glypar PM 1mg/500mg/15mg Tablet whole; do not damage it by chewing, crushing, or breaking. Administer this medication with a meal.
How Glypar PM 1mg/500mg/15mg Tablet works:
Glypar PM, a 1mg/500mg/15mg tablet, combines glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct modes of action. This triple therapy improves blood glucose management when single or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glypar PM 1mg/500mg/15mg tablets is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Glypar PM 1mg/500mg/15mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Glypar PM 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available evidence from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glypar PM 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glypar PM 1mg/500mg/15mg tablets. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glypar PM 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Glypar PM 1mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glypar PM 1mg/500mg/15mg Tablet :
Should you forget to take your Glypar PM 1mg/500mg/15mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.
Facts to Know About Glypar PM 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently